Skip to content
Low DoseGLP-1Providers

Provider review

Healthon review

One entry figure for a doctor-led plan, with neither molecule priced separately.

Reviewed by Lena OrtizMetabolic Health Editor

Price updated August 2026

We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.

From $189/mo, neither molecule priced separately

Visit Healthon

The figure is mid-range and visible up front. Nothing published says which molecule the program uses, or what happens above the starting point.

Price as published

Healthon

From $189/mo, neither molecule priced separately

FDA warning letter · Healthon · September 2025 · addressed to Healthon Inc. dba Healthon. Details in our review.

Vs median
$14/mo above the $175 median
Market
$59–$1,300/mo across 299 of 548
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

In one paragraph

The verdict

The entry figure is mid-range for this category and the program is described as doctor-led and personalized, with a broader longevity and skin catalog priced alongside it. What a reader cannot do here is any of the arithmetic this site exists to help with. The weight-loss figure is a starting point with nothing published about what it starts from — not a dose, not a plan length, not a molecule. Neither semaglutide nor tirzepatide is priced separately, so the two cannot be compared, and nothing on the page establishes which one a reader would actually receive or whether they get any choice in it. That combination is common enough in this category to be unremarkable, but it does mean the published number tells you roughly what the cheapest version of something costs without telling you what the something is. If the wider longevity catalog is part of the appeal, its pricing is presented the same way and is at least easier to compare against other sellers, because those products are more standardized than a personalized GLP-1 plan can be.

Visit Healthon

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

Who it suits, and who it does not

A good fit if

  • You want a mid-range entry figure visible before any intake.
  • You want the plan described as doctor-led rather than automated.
  • You are interested in the longevity and skin lines alongside weight loss.

Look elsewhere if

  • You want to know which molecule you would receive. Nothing published says.
  • You want to compare semaglutide against tirzepatide. Neither is priced separately.
  • You need a ceiling. The figure is a starting point only.

What it actually costs

Price as published

From $189/mo, neither molecule priced separately

Vs median
$14/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
Market
$59–$1,300/mo is the full published spread on this site
Structure
Standard plan, self-directed low dose

No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.

235 of the 548 programs here price a small dose this way. One "start from" figure covers the whole weight-loss program and neither molecule is priced separately, so nothing is readable per molecule before intake and nothing published says which one a reader receives. No low-dose product is offered.

See Healthon's current price

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

What is included

Consult
Included in the price
Dietitian
Not confirmed
Labs
Not required
Pricing
Check plan terms

What it does well

  • The entry figure is mid-range and visible before any intake.
  • The program is described as doctor-led and personalized rather than automated.
  • A broader longevity and skin catalog is priced on the same site.

Pharmacy, labs and oversight

Healthon does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Transparency check

0 of 4 published openly

What Healthon publishes about itself, read from its own pages when we verified them — not estimated, and not a score.

Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
Not published
A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
Not published
What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
Not published
FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
On file

FDA warning letter

The U.S. Food and Drug Administration issued a warning letter to Healthon in September 2025. It is addressed to Healthon Inc. dba Healthon — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how Healthon is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.

Search the FDA warning-letter database →

How the program works

The entry figure is mid-range for this category and the program is described as doctor-led and personalized, with a broader longevity and skin catalog priced alongside it. What a reader cannot do here is any of the arithmetic this site exists to help with. The weight-loss figure is a starting point with nothing published about what it starts from — not a dose, not a plan length, not a molecule. Neither semaglutide nor tirzepatide is priced separately, so the two cannot be compared, and nothing on the page establishes which one a reader would actually receive or whether they get a choice. That combination is common enough in this category to be unremarkable, but it does mean the published number tells you roughly what the cheapest version of something costs without telling you what the something is. If the wider longevity catalog is part of the appeal, the pricing there is presented the same way and is easier to compare against other sellers, because those products are more standardized than a personalized GLP-1 plan.

The honest cons

Every figure is a "start from" with no ceiling published.
  • Neither molecule is priced separately, so the two cannot be compared.
  • No dose is published, and nothing says which molecule the program uses.
Visit Healthon

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

How it compares

Healthon is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Also consider

Two more programs that price a small dose the way Healthon does. Both are partners: we may earn a commission if you start care through these links.

Partner

RxSpan MD

$249/mo month to month ($199 on 6-mo)

Standard plan, self-directed low dose

Partner

HealthRX

$190/mo sema · $239/mo tirz (monthly plan)

Standard plan, self-directed low dose

Where this sits

#224 of 548

Ordered with the companies that pay us first, and Healthon is not one of them. A disclosed partition, not a score.

Compare all 548 providers →

Read this before you buy

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

Start with Healthon

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.

The closest alternative

Peter MD

$149/mo GLP1+B12 · $249/mo tirz (quarterly)

Vs median
$26/mo below the $175 median
Market
$59–$1,300/mo across 299 of 548
Structure
Standard plan, self-directed low dose
Dispensed
Pharmacy not publicly identified

Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.

Read the Peter MD review →

Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.